Comorbid Depression among Untreated Illicit Opiate Users: Results from a Multisite Canadian Study

Objectives: This study aimed to describe patterns of major depression (MDD) in a cohort of untreated illicit opiate users recruited from 5 Canadian urban centres, identify sociodemographic characteristics of opiate users that predict MDD, and determine whether opiate users suffering from depression exhibit different drug use patterns than do participants without depression. Method: Baseline data were collected from 679 untreated opiate users in Vancouver, Edmonton, Toronto, Montreal, and Quebec City. Using the Composite International Diagnostic Interview Short Form for Major Depression, we assessed sociodemographics, drug use, health status, health service use, and depression. We examined depression rates across study sites; logistic regression analyses predicted MDD from demographic information and city. Chi-square analyses were used to compare injection drug use and cocaine or crack use among participants with and without depression. Results: Almost one-half (49.3%) of the sample met the cut-off score for MDD. Being female, white, and living outside Vancouver independently predicted MDD. Opiate users suffering from depression were more likely than users without depression to share injection equipment and paraphernalia and were also more likely to use cocaine (Ps < 0.05). Conclusions: Comorbid depression is common among untreated opiate users across Canada; targeted interventions are needed for this population.

[1]  Nicholas Walliman,et al.  Social research methods , 2006 .

[2]  F. Leri,et al.  Patterns of opioid and cocaine co-use: a descriptive study in a Canadian sample of untreated opioid-dependent individuals. , 2005, Experimental and clinical psychopharmacology.

[3]  Jennifer L. Anthony,et al.  Pharmacotherapy plus psychotherapy for treatment of depression in active injection drug users. , 2004, Archives of general psychiatry.

[4]  T. Brugha,et al.  Substance misuse and psychiatric comorbidity: an overview of the OPCS National Psychiatric Morbidity Survey. , 1998, International review of psychiatry.

[5]  F. Leri,et al.  Understanding polydrug use: review of heroin and cocaine co-use. , 2003, Addiction.

[6]  F. Smit,et al.  Risk factors for 12-month comorbidity of mood, anxiety, and substance use disorders: findings from the Netherlands Mental Health Survey and Incidence Study. , 2002, The American journal of psychiatry.

[7]  C. Moore,et al.  Comparison of point-of-collection screening of drugs of abuse in oral fluid with a laboratory-based urine screen. , 2001, Forensic science international.

[8]  C. Latkin,et al.  Longitudinal predictors of depressive symptoms among low income injection drug users , 2001, AIDS care.

[9]  A. Swain,et al.  COMORBIDITY IN A CLINICAL SAMPLE OF SUBSTANCE ABUSERS , 2001, The American journal of drug and alcohol abuse.

[10]  A. Bryman Social Research Methods , 2001 .

[11]  W. Compton,et al.  Psychiatric disorders among drug dependent subjects: are they primary or secondary? , 2000, The American journal on addictions.

[12]  L B Cottler,et al.  Substance dependence and other psychiatric disorders among drug dependent subjects: race and gender correlates. , 2000, The American journal on addictions.

[13]  S. Patten,et al.  Performance of the composite international diagnostic interview short form for major depression in a community sample. , 2000, Chronic diseases in Canada.

[14]  Olga V. Demler,et al.  Cross-national comparisons of the prevalences and correlates of mental disorders. WHO International Consortium in Psychiatric Epidemiology. , 2000, Bulletin of the World Health Organization.

[15]  R. Kessler,et al.  Psychiatric epidemiology: selected recent advances and future directions. , 2000, Bulletin of the World Health Organization.

[16]  C. Latkin,et al.  Depressive symptoms, drug network, and their synergistic effect on needle-sharing behavior among street injection drug users. , 1999, The American journal of drug and alcohol abuse.

[17]  R. Kessler,et al.  The World Health Organization Composite International Diagnostic Interview short‐form (CIDI‐SF) , 1998 .

[18]  Beth E. Molnar,et al.  Comorbidity of substance use disorders with mood and anxiety disorders: results of the International Consortium in Psychiatric Epidemiology. , 1998, Addictive behaviors.

[19]  Charles B. Fleming,et al.  A meta-analysis of predictors of continued drug use during and after treatment for opiate addiction. , 1998, Addiction.

[20]  E. Isometsä,et al.  Depression in Finland: a computer assisted telephone interview study , 1997, Acta psychiatrica Scandinavica.

[21]  R. Kessler,et al.  Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey. , 1997, Archives of general psychiatry.

[22]  R. Brooner,et al.  Psychiatric and substance use comorbidity among treatment-seeking opioid abusers. , 1997, Archives of general psychiatry.

[23]  D. Offord,et al.  One-Year Prevalence of Psychiatric Disorder in Ontarians 15 to 64 Years of Age , 1996, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[24]  J. Lieberman,et al.  Incidence and Correlates of Tardive Dyskinesia in First Episode of Schizophrenia , 1996 .

[25]  J. Berg Book Review: Screening for Down's Syndrome , 1996 .

[26]  R. Kessler,et al.  The epidemiology of co-occurring addictive and mental disorders: implications for prevention and service utilization. , 1996, The American journal of orthopsychiatry.

[27]  J. Gorman,et al.  Psychopathology in male and female intravenous drug users with and without HIV infection. , 1994, The American journal of psychiatry.

[28]  R. Kessler,et al.  Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. , 1994, Archives of general psychiatry.

[29]  Chuan Yi Tang,et al.  A 2.|E|-Bit Distributed Algorithm for the Directed Euler Trail Problem , 1993, Inf. Process. Lett..

[30]  C. Robert Cloninger,et al.  Psychiatric comorbidity and suicidality among intravenous drug users. , 1992, The Journal of clinical psychiatry.

[31]  G. Woody,et al.  Risk factors for needle sharing among methadone-treated patients. , 1991, The American journal of psychiatry.

[32]  D S Rae,et al.  Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. , 1990, JAMA.

[33]  R. Bland,et al.  LIFETIME PREVALENCE OF PSYCHIATRIC DISORDERS IN EDMONTON , 1988, Acta psychiatrica Scandinavica. Supplementum.

[34]  B. Rounsaville,et al.  A 2.5-year follow-up of depression, life crises, and treatment effects on abstinence among opioid addicts. , 1986, Archives of general psychiatry.

[35]  B. Rounsaville,et al.  Untreated opiate addicts. How do they differ from those seeking treatment? , 1985, Archives of general psychiatry.

[36]  M. Weissman,et al.  Diagnosis and symptoms of depression in opiate addicts. Course and relationship to treatment outcome. , 1982, Archives of general psychiatry.

[37]  M. Weissman,et al.  Heterogeneity of psychiatric diagnosis in treated opiate addicts. , 1982, Archives of general psychiatry.